Search

everythinglearnresearchcommunity

for

Search:↓

New gel formulas without ethanol and propylene glycol, containing a minoxidil-methyl-β-cyclodextrin complex, have been created for treating hair loss.

Mice with autoimmune hair loss showed signs of heart problems.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Young female Australian fur seals are losing hair due to low tyrosine and zinc levels and high pollution exposure.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Wigs significantly improve the well-being of people with severe hair loss.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Tamoxifen caused hair loss in a 52-year-old woman.

Alopecia areata may be linked to imbalanced gut bacteria.

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

A genetic mutation in the SGK3 gene causes hairlessness in Scottish Deerhounds and may relate to human hair loss.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

M30 is a promising treatment for preventing hair loss during chemotherapy.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

PRP therapy for alopecia shows inconsistent results due to natural variability in growth factor secretion by platelets.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.